STOCKHOLM, SWEDEN – July 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces an update from Organon on the development of the drug candidate OG-6219, acquired by Organon through its acquisition of Forendo Pharma in 2021. Following results from a Phase 2 clinical study with OG-6219, Organon plans to discontinue the clinical development of the drug candidate.
VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and data center technology company, today announces its preliminary operational results for June 2025:
MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.
LINGSHUI, China, July 3, 2025 /PRNewswire/ -- The organizers of the HaiNan-Southeast Asia AI Hardware Battle (HNSE AHB) are pleased to announce an expanded prize...
SUNNYVALE, Calif., July 2, 2025 /PRNewswire/ -- Today, Synopsys, Inc. (Nasdaq: SNPS) issued the below statement in connection with the lifting of recent U.S. export...
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized consumer rights law firm, is investigating potential claims against Ruffolo, Hooper & Associates, MD, PA (“Ruffolo, Hooper & Associates, MD, PA” or the “Company”) on behalf of Ruffolo, Hooper & Associates, MD, PA consumers. Our investigation concerns whether Ruffolo, Hooper & Associates, MD, PA has violated consumer protection laws and/or engaged in other unlawful business practices.
BOGOTA, Colombia, July 2, 2025 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC, the "Company" or "Ecopetrol") reports that, on June 3, 2025, the...
INDIANAPOLIS and DENVER, July 2, 2025 /PRNewswire/ -- After 4 years in development, Lore Link is now publicly available as an online management tool...
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight on an expanded array of exceptional drink experiences across the region, Asia's 50 Best Bars,...
The fifth edition of this prestigious list welcomes 14 new entries representing 23 destinations across Asia
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight...
The fifth edition of this prestigious list welcomes 14 new entries representing 23 destinations across Asia
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight...
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight on an expanded array of exceptional drink experiences across the region, Asia's 50 Best Bars,...